Ipca Laboratories Limited
IPCALAB
Rankning i aktier
#3415
Ipca Laboratories Limited, an integrated pharmaceutical company, manufactures... Ipca Laboratories Limited, an integrated pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India, Europe, Africa, the Americas, Asia, the Commonwealth of Independent States, and Australasia. The company offers APIs in anti-hypertensive, anti-malarial, diuretic, DMARD, anti-hypertensive, and anthelmintic therapeutic areas. It also provides generic and branded formulations in various therapeutic segments, including allergy, anti-neoplastic/cancer drugs, anti-arthritic, anti-epileptic, anti-hypertensive, cardiology, diabetes, dermatology, diabetology, emollients/protectives, fever, gastroenterology, helminthics, hepatoprotectives, immunosuppressant, infectious diseases, malaria, neurology, neuropathic pain, and NSAIDs, as well as nutraceuticals, ophthalmology, oral anti diabetes drug, orthopedics, probiotics, psychiatry, respiratory, rheumatology, and urology. The company also exports its products worldwide. Ipca Laboratories Limited was incorporated in 1949 and is based in Mumbai, India.
Aktiekurs
$20.02
Senast synkroniserad: 2026-10-19
Marknadsvärde
$5.08B
Förändring (1 dag)
-1.65%
Förändring (1 år)
38.46%
Land
IN
Handel Ipca Laboratories Limited (IPCALAB)
Kategori
Healthcare
P/S-tal för Ipca Laboratories Limited (IPCALAB)
P/S-tal per October 2026 TTM: 4.79
Enligt Ipca Laboratories Limited senaste finansiella rapporter och aktiekurs är det aktuella P/S-talet (TTM) 4.79. I slutet av 2024 hade företaget ett P/S-tal på 4.09.
Historik för P/S-tal för Ipca Laboratories Limited från 2005 till 2026
P/S-tal vid årets slut
| År | P/S-tal | Ändra |
|---|---|---|
| 2026 (TTM) | 4.79 | 21.18% |
| 2025 | 3.95 | -3.41% |
| 2024 | 4.09 | 23.36% |
| 2023 | 3.31 | -29.36% |
| 2022 | 4.69 | 4.36% |
| 2021 | 4.49 | 16.46% |
| 2020 | 3.86 | 15.92% |
| 2019 | 3.33 | 27.17% |
| 2018 | 2.62 | 2.84% |
| 2017 | 2.55 | -1.43% |
| 2016 | 2.58 | 0.29% |
| 2015 | 2.57 | -21.59% |
| 2014 | 3.28 | 37.60% |
| 2013 | 2.39 | 33.22% |
| 2012 | 1.79 | -9.72% |
| 2011 | 1.98 | -7.96% |
| 2010 | 2.16 | 233.52% |
| 2009 | 0.65 | -56.00% |
| 2008 | 1.47 | -8.30% |
| 2007 | 1.60 | 38.75% |
| 2006 | 1.15 | 4.46% |
| 2005 | 1.11 | 0.00% |
P/S-tal för liknande företag eller konkurrenter
| Företag | P/S-tal | Skillnad i P/S-tal | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 7.06 | 47.45% |
IN
|
